CCR2 and neoplasm: Collectively, these data reveal that CCR2 is highly expressed in intratumoral myeloid cells on the majority of primary NSCLC, PDACs, and CRCs and that high CCR2 is associated with enhanced local adaptive immune responses and specific clinical and molecular tumor subsets.